Ipscell iconIpscellSep 13, 2026

Weekly reads: suite of reprogramming news, cancer trial reform, zombie retracted papers

Before we jump into weekly reads including on reprogramming applications, on the 20th anniversary of iPS cells, enter our $200 stem cell contest.

Share this story

Send the public story page.

Useful takeaways from this story.

Before we jump into weekly reads including on reprogramming applications, on the 20th anniversary of iPS cells, enter our $200 stem cell contest.

The stream of research pubs and news articles continues to grow.

Do you buy the idea of using in vivo reprogramming to fight aging?

Building the complete brief

The page is ready to read now. The fuller skim-friendly version will appear here automatically.

The useful part

Before we jump into weekly reads including on reprogramming applications, on the 20th anniversary of iPS cells, enter our $200 stem cell contest. Do you buy the idea of using in vivo reprogramming to fight aging? The stream of research pubs and news articles continues to grow.

How it works

  • The stream of research pubs and news articles continues to grow.

Details worth keeping

Do you buy the idea of using in vivo reprogramming to fight aging?

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app